Liver Transplant for Decompensated Cirrhosis: When to Ask for a Referral and What Happens Next

TL;DR

• Liver transplant evaluation may be discussed after decompensated cirrhosis develops, especially after serious complications such as ascites, hepatic encephalopathy, or variceal bleeding.
• Referral is not the same as being placed on the transplant waiting list. Evaluation comes first.
• Testing usually considers liver disease severity, heart and lung health, infections, cancer, frailty, nutrition, substance use, psychosocial factors, and available support.
• Eligibility can change. A temporary medical problem may delay or pause transplantation without necessarily meaning someone can never receive a transplant.
• In mama health patient conversations, the biggest information gap was simple: patients wanted to understand why they were — or were not — being listed and what happens next.

When should liver transplant referral be discussed?

Liver transplant referral can be worth discussing once cirrhosis has decompensated, rather than waiting for repeated crises or one specific MELD score.

AASLD guidance recommends considering transplant evaluation in people who develop clinically significant ascites and related complications. More recent AASLD educational guidance describes referral as generally appropriate after a first decompensating event, such as ascites, variceal bleeding, hepatic encephalopathy, or jaundice, or when MELD reaches a level associated with greater short-term risk.

Patients rarely describe the decision this way. Among mama health's Italian patients who had a recorded hospitalisation, the transplant conversation most often began after a serious event: severe hepatic encephalopathy, gastrointestinal bleeding, recurrent ascites requiring paracentesis, or worsening jaundice and weakness.

A useful question for someone who has experienced a major complication could therefore be: "Would it be appropriate to discuss evaluation at a transplant centre?"

Referral practices and eligibility criteria vary between countries and transplant centres.

Does being referred mean you will get a liver transplant?

No. Referral means a specialist transplant team assesses whether transplantation could be appropriate; it does not guarantee listing or surgery.

In mama health's patient conversations, liver transplantation appeared somewhere in a meaningful minority of treatment journeys — though most of those were still at the discussion stage rather than listed or transplanted. A smaller number had been listed but not yet transplanted, and a smaller number still had actually received a transplant.

These patterns describe mama health's own patient conversations and shouldn't be read as transplant rates for people with cirrhosis generally.

They do illustrate something patients often find confusing: talking about transplant, being evaluated, being listed, and actually receiving a transplant are separate stages.

What happens during liver transplant evaluation?

Transplant evaluation is a multidisciplinary assessment of whether transplantation is likely to provide more benefit than risk for an individual patient.

Patients described to mama health an intensive series of appointments and tests. Assessment may include liver imaging and blood tests, heart and lung evaluation, infection screening, cancer assessment, nutritional and frailty assessment, review of other medical conditions, psychosocial assessment, discussion of alcohol or other substance use when relevant, and evaluation of support and practical circumstances.

Updated AASLD and EASL guidelines place particular emphasis on comprehensive candidate assessment, including cardiovascular health, frailty, sarcopenia, infection risk, cancer screening, and psychosocial factors.

Meanwhile, treatment for cirrhosis usually continues. Patients may still need medicines for ascites or hepatic encephalopathy and procedures for complications while evaluation is taking place.

Can age, infection, or other health problems prevent transplantation?

Some medical and psychosocial factors can affect transplant eligibility, but candidacy is usually based on an overall assessment rather than one factor alone.

Patients who talked to mama health about transplant barriers frequently worried about being "too old," previous cancer, heart disease, infections, physical deconditioning, fractures, or alcohol or substance use.

These concerns do not all represent permanent contraindications. For example, active uncontrolled infection can make transplantation temporarily unsafe. Frailty is associated with worse outcomes, but AASLD notes that frailty or sarcopenia alone should not automatically exclude someone from transplantation. Similarly, older age requires careful assessment but does not automatically answer whether transplantation is possible.

This distinction matters because patients sometimes interpreted "not suitable now" as "never suitable."

Asking the transplant team whether a barrier is temporary, modifiable, or permanent can make the decision easier to understand.

Is six months of alcohol abstinence always required?

No universal six-month abstinence rule applies to every liver transplant candidate.

Alcohol abstinence remains extremely important for people with alcohol-related liver disease, but transplant practice has moved away from using a fixed six-month period as the only criterion for selection.

Modern assessment considers factors such as sustained commitment to abstinence, previous alcohol use, addiction treatment, psychiatric health, social support, and risk of returning to harmful drinking.

Policies can still vary by centre and country. Patients should therefore ask their own transplant programme to explain its criteria rather than assuming that one fixed timeline applies everywhere.

Why can someone be temporarily removed or suspended from the transplant list?

Listing status can change when a new health problem alters the balance between the risks and benefits of surgery.

Patients told mama health about anxiety after listing was paused because of new medical problems, including infection, injury, or worsening physical condition.

A pause does not always mean permanent removal. A transplant team may reassess candidacy when circumstances change. This is why patients may benefit from asking:

• Why has my status changed?
• Is this temporary or permanent?
• What needs to change before I can be reconsidered?
• When will my case be reviewed again?

Patients repeatedly described clear written explanations of these decisions as something they wished they had received earlier.

What is waiting for a transplant like?

Waiting can involve managing advanced cirrhosis while knowing that medical status may change quickly.

Patients described profound fatigue, muscle loss, recurrent hepatic encephalopathy, infections, and difficulty maintaining everyday independence.

They also described the emotional difficulty of waiting without knowing exactly when — or whether — a suitable organ would become available.

Travel created another burden. Some families had to manage long distances to transplant centres, time away from work, accommodation, and caregiving responsibilities.

For many patients, practical planning became almost as important as understanding the medical process.

What happens after a liver transplant?

After transplantation, the focus shifts from managing the failing liver to protecting the transplanted liver and adapting to long-term follow-up.

Recipients need immunosuppressive medicines to reduce the risk of rejection. Most liver transplant recipients require long-term immunosuppression, with treatment individualized according to rejection risk, kidney function, infections, cancer risk, and medication side effects.

Patients who had undergone transplantation described the experience to mama health as a major new beginning, but not the end of healthcare.

Regular follow-up, medication adherence, blood testing, and adapting to side effects become part of life after transplant.

What do patients wish they had known about transplant referral?

Patients most often wanted clearer explanations of the pathway, not more medical terminology.

Four questions kept returning across mama health's patient conversations: when should transplant evaluation begin? What exactly determines whether I qualify? Why has my listing status changed? What happens next?

That communication gap matters. For patients, transplant often represents the point where prognosis becomes tangible. Being evaluated can create hope. Being delayed or declined can feel like a second diagnosis.

Clear information about what is happening — and whether a barrier is temporary or permanent — can make the pathway easier for patients and caregivers to understand.

What questions can you take to your hepatologist?

Preparing a few specific questions can help clarify where you are in the transplant pathway.

You could ask:

• Would transplant-centre evaluation be appropriate to discuss now?
• What factors currently affect my eligibility?
• Am I being referred, evaluated, or already listed?
• Is there anything currently delaying my evaluation?
• If I am not eligible now, could that change?
• How does my MELD score affect the transplant discussion?
• What support will my caregiver need to provide?
• Who should I contact if my condition changes while I am waiting?

These questions support conversations with a healthcare professional and are not personalized medical recommendations.

Disclaimer: This content is informational and not a medical device. mama health offers information and support and does not replace a doctor.